Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Asthma children
100%
Montelukast
100%
Leukotriene Receptor Antagonist
100%
Persistent Asthma
100%
Asthma
69%
Asthma Symptoms
53%
Adverse Effects
46%
Placebo
38%
Caregivers
38%
Asthma Control
38%
Treatment Group
30%
β-agonists
30%
Chewable Tablets
30%
Preschool children
23%
Asthma Attack
23%
Cromolyn
23%
Once-daily
15%
Baseline Period
15%
Safety Profile
15%
Young children
15%
Mean Group
15%
Cough
15%
Rescue Medication
15%
Multiple Parameters
15%
Peripheral Blood Eosinophils
15%
Radioallergosorbent Test
15%
Confidence Interval
7%
No Significant Difference
7%
Placebo Groups
7%
Activity Limitations
7%
Number of Patients
7%
Europe
7%
Twice Daily
7%
Clinically Significant
7%
Adult Patients
7%
Orally Administered
7%
Between-group Difference
7%
Intention-to-treat
7%
United States
7%
Statistical Analysis
7%
Age Groups
7%
Fisher's Exact Test
7%
Corticosteroids
7%
Eosinophils
7%
Eosinophil Count
7%
Patient-completed
7%
Central Laboratory
7%
Children Younger than 5 Years
7%
Change from Baseline
7%
Clinically Meaningful Difference
7%
Australia
7%
Long-term Tolerability
7%
North America
7%
Quality of Life Improvement
7%
Inhaled Corticosteroids
7%
Effective Therapy
7%
Quality of Life Questionnaire
7%
Clinical Benefit
7%
Clinical Utility
7%
South America
7%
Wheezing
7%
Concomitant Use
7%
Daily Use
7%
Unblinding
7%
Pediatric Patients
7%
Africa
7%
Dose Delivery
7%
Treatment Study
7%
Clinic Visits
7%
Asthma Treatment
7%
Quality of Life Assessment
7%
Analysis of Covariance
7%
Specified Time
7%
Between-group Comparisons
7%
Diary Card
7%
Inhaled Therapy
7%
Oral Corticosteroids
7%
Controller Therapy
7%
Baseline Measurements
7%
Very Young Patients
7%
Design Analysis
7%
Post-randomization
7%
Physician-diagnosed Asthma
7%
Asthma Quality of Life
7%
Inhaler
7%
Tachyphylaxis
7%
Elevated Transaminases
7%
Transaminase Levels
7%
Blood Eosinophil Count
7%
Variance Model
7%
Corticosteroid Use
7%
Pre-analysis Plan
7%
Caregiver Quality of Life
7%
Routine Diagnostic Tests
7%
Narrow Therapeutic Index
7%
Medicine and Dentistry
Asthma
100%
Montelukast
100%
Leukotriene Receptor Blocking Agent
100%
Asthma in Children
100%
Placebo
19%
Adverse Event
19%
Symptom
16%
Group Therapy
12%
Beta Adrenergic Receptor Stimulating Agent
12%
Eosinophil
12%
Quality of Life
9%
Toddlers
9%
Preschooler
9%
Cromoglycate Disodium
9%
Drug Therapy
6%
Emergency Medical Technician
6%
Cough
6%
Radioallergosorbent Test
6%
Prevalence
3%
Intention-to-Treat Analysis
3%
Breathing
3%
Physical Examination
3%
Fisher Exact Test
3%
Therapeutic Window
3%
Wheeze
3%
Pediatrics Patient
3%
Analysis of Variance
3%
Laboratory Test
3%
Analysis of Covariance
3%
Transaminase
3%
Tachyphylaxis
3%
Immunology and Microbiology
Asthma
100%
Asthma in Children
100%
Leukotriene Antagonist
100%
Montelukast
100%
Beta-Adrenergic Agonist
12%
Cromoglicic Acid
9%
Radioallergosorbent Test
6%
Eosinophil Count
6%
Prevalence
3%
Eosinophil Granulocyte
3%
Eosinophil
3%
Breathing
3%
Laboratory Test
3%
Tachyphylaxis
3%
Aminotransferase Blood Level
3%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Leukotriene Receptor Blocking Agent
100%
Montelukast
100%
Symptom
21%
Adverse Event
18%
Placebo
18%
Tablet
12%
Beta Adrenergic Receptor Stimulating Agent
12%
Cromoglicic Acid
9%
Coughing
6%
Prevalence
3%
Tolerability
3%
Therapeutic Window
3%
Wheezing
3%
Aminotransferase
3%
Tachyphylaxis
3%